| scholarly article | Q13442814 |
| P50 | author | Gerald N Rechberger | Q47503277 |
| Harald Köfeler | Q52797507 | ||
| Zlatko Trajanoski | Q61161265 | ||
| Hubert Hackl | Q41547884 | ||
| P2093 | author name string | Wolfgang Sattler | |
| Manfred Kollroser | |||
| Albin Hermetter | |||
| Ernst Malle | |||
| Andreas Ullen | |||
| Christoph Nusshold | |||
| Eva Bernhart | |||
| Helga Reicher | |||
| Sabine Waltl | |||
| Andelko Hrzenjak | |||
| Ingrid Kratzer | |||
| P2860 | cites work | Chloramines and hypochlorous acid oxidize erythrocyte peroxiredoxin 2 | Q43283857 |
| Effects of hypochlorous acid on unsaturated phosphatidylcholines | Q43777199 | ||
| Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood-brain barrier model | Q44007456 | ||
| Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions | Q44668967 | ||
| Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact | Q44766213 | ||
| Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. | Q44962228 | ||
| Neuronal expression of myeloperoxidase is increased in Alzheimer's disease | Q44980217 | ||
| Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury | Q45244976 | ||
| Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. | Q45297626 | ||
| The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study | Q45393883 | ||
| Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease | Q46454909 | ||
| Hypochlorous acid-derived modification of phospholipids: characterization of aminophospholipids as regulatory molecules for lipid peroxidation | Q48364372 | ||
| Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis | Q48615832 | ||
| Elevated myeloperoxidase activity in white matter in multiple sclerosis. | Q48954285 | ||
| Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1 | Q71070355 | ||
| Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes | Q72130322 | ||
| Fatty acid chlorohydrins and bromohydrins are cytotoxic to human endothelial cells | Q73828481 | ||
| Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis | Q80089503 | ||
| A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis | Q24644684 | ||
| Identification of genes involved in ceramide-dependent neuronal apoptosis using cDNA arrays | Q24802601 | ||
| Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 | ||
| Mitochondrial fragmentation in neurodegeneration | Q28284588 | ||
| Mass-spectrometric characterization of phospholipids and their primary peroxidation products in rat cortical neurons during staurosporine-induced apoptosis | Q28391477 | ||
| Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells | Q28565237 | ||
| Impairment of glucose metabolism in hearts from rats treated with endotoxin | Q28577350 | ||
| Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? | Q29042454 | ||
| Oxidative stress and neurodegeneration: where are we now? | Q29617324 | ||
| Myeloperoxidase: friend and foe | Q29619070 | ||
| Genesis: cluster analysis of microarray data | Q29619630 | ||
| Sphingosine-1-phosphate: an enigmatic signalling lipid | Q29620563 | ||
| Evaluation of products upon the reaction of hypohalous acid with unsaturated phosphatidylcholines | Q30758418 | ||
| Modification of phosphatidylserine by hypochlorous acid | Q33478255 | ||
| Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis | Q33708751 | ||
| Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal | Q33942370 | ||
| Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols | Q34396293 | ||
| The ether lipid-deficient mouse: tracking down plasmalogen functions | Q34572093 | ||
| Activity-dependent regulation of energy metabolism by astrocytes: an update | Q34656867 | ||
| Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? | Q35047134 | ||
| Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid | Q36477710 | ||
| Chlorinative stress: an under appreciated mediator of neurodegeneration? | Q36588579 | ||
| Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases | Q36683909 | ||
| The mitochondrial permeability transition in neurologic disease | Q36775895 | ||
| Myeloperoxidase: a target for new drug development? | Q36860606 | ||
| Chlorinated lipids and fatty acids: an emerging role in pathology. | Q36894159 | ||
| Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease | Q37075304 | ||
| Presence of hypochlorite-modified proteins in human atherosclerotic lesions | Q37353371 | ||
| Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. | Q39575996 | ||
| Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells | Q40121297 | ||
| Fatty acid and phospholipid chlorohydrins cause cell stress and endothelial adhesion. | Q40204124 | ||
| Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells | Q40229841 | ||
| Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells. | Q40269791 | ||
| Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human fetal liver cells: role of mitochondrial permeability transition | Q40417233 | ||
| A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria. | Q40498233 | ||
| 2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. | Q40498512 | ||
| Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier | Q41199461 | ||
| Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes | Q42138423 | ||
| Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-I. | Q42995934 | ||
| P433 | issue | 12 | |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 1588-1600 | |
| P577 | publication date | 2010-03-11 | |
| P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
| P1476 | title | Hypochlorite modification of sphingomyelin generates chlorinated lipid species that induce apoptosis and proteome alterations in dopaminergic PC12 neurons in vitro | |
| P478 | volume | 48 |
| Q41763286 | A versatile ultra-high performance LC-MS method for lipid profiling |
| Q38818896 | Assessment of electrophile damage in a human brain endothelial cell line utilizing a clickable alkyne analog of 2-chlorohexadecanal. |
| Q87789966 | Bromofatty aldehyde derived from bromine exposure and myeloperoxidase and eosinophil peroxidase modify GSH and protein |
| Q104559091 | Direct acting antiviral therapy rescues neutrophil dysfunction and reduces hemolysis in hepatitis C infection |
| Q39668852 | Formation of chlorinated lipids post-chlorine gas exposure |
| Q42940917 | High-throughput phospholipidic fingerprinting by online desorption of dried spots and quadrupole-linear ion trap mass spectrometry: evaluation of atherosclerosis biomarkers in mouse plasma |
| Q35536367 | Identification of glutathione adducts of α-chlorofatty aldehydes produced in activated neutrophils |
| Q36935441 | Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons |
| Q42615245 | Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia |
| Q35074231 | Mass spectrometry and inflammation--MS methods to study oxidation and enzyme-induced changes of phospholipids |
| Q33770447 | Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo |
| Q89681951 | Myeloperoxidase and Septic Conditions Disrupt Sphingolipid Homeostasis in Murine Brain Capillaries In Vivo and Immortalized Human Brain Endothelial Cells In Vitro |
| Q41596971 | Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro |
| Q47856535 | Role of Peroxiredoxin 2 in the Protection Against Ferrous Sulfate-Induced Oxidative and Inflammatory Injury in PC12 Cells |
| Q60596773 | Study of sphingolipids oxidation by ESI tandem MS |
Search more.